DJIA 17,949.59 -85.34 -0.47%
NASDAQ 5,014.10 19.50 0.39%
S&P 500 2,097.29 -3.11 -0.15%
market minute promo

Gilead Sciences (NASDAQ: GILD)

company name or ticker
Company Photos
(Click to zoom)

Benzinga's M&A Chatter for Tuesday April 21, 2015

5 Reasons To Consider Gilead

Gilead (GILD) Marked As A Barbarian At The Gate

Forget Gilead (GILD), Buy These Impressive Biotech Stocks Instead - Analyst Blog

Gilead-Vertex Deal Has 'Low Probability' Of Happening, RBC Capital Says

Stocks Are Mixed as Earnings Dent Dow, Deals Boost Nasdaq

Weekly CFO Sells Highlight: Gilead Sciences Inc, CarMax Inc, Anthem Inc.

Gilead Sciences: Serious Cash Means An Acquisition Could Be Coming Soon

Positioning For A Catalyst-Heavy 2015 In Achillion Pharmaceuticals

Double-Digit Spike in Drug Costs Prescribes Profits for PBMs

A new report by employee benefit consultancy Aon Hewitt forecasts a 10% increase in employer drug costs through 2017, which puts a spotlight on pharmacy benefit management companies to assist employers, health plans, and government insurers such as Medicare and Medicaid to control prescription spending.
See More Articles...